| Date Filed | Type | Description |
| 01/06/2023 |
4
| Brown Dennis M (Chief Scientific Officer) has filed a Form 4 on Kintara Therapeutics, Inc.|
Txns:
| Acquired (by will) 363 shares
@ $0 |
|
| 08/03/2022 |
4
| Praill Anthony Scott (CFO) has filed a Form 4 on Kintara Therapeutics, Inc.|
Txns:
| Granted 240,087 shares
@ $0
Granted 720,260 options to buy
@ $0.1757, valued at
$126.5k
|
|
| 08/03/2022 |
4
| Brown Dennis M (Chief Scientific Officer) has filed a Form 4 on Kintara Therapeutics, Inc.|
Txns:
| Granted 240,087 shares
@ $0
Granted 720,260 options to buy
@ $0.1757, valued at
$126.5k
|
|
| 08/03/2022 |
4
| Hoffman Robert E. (President and CEO) has filed a Form 4 on Kintara Therapeutics, Inc.|
Txns:
| Granted 400,145 shares
@ $0
Granted 1,200,634 options to buy
@ $0.1757, valued at
$211k
|
|
| 07/05/2022 |
4
| Johnson Laura L. (Director) has filed a Form 4 on Kintara Therapeutics, Inc.|
Txns:
| Granted 100,000 options to buy
@ $0.255, valued at
$25.5k
|
|
| 07/05/2022 |
4
| TOTH ROBERT JOSEPH JR (Director) has filed a Form 4 on Kintara Therapeutics, Inc.|
Txns:
| Granted 100,000 options to buy
@ $0.255, valued at
$25.5k
|
|
| 07/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/17/2022 |
4
| Hoffman Robert E. (President and CEO) has filed a Form 4 on Kintara Therapeutics, Inc.|
Txns:
| Bought 55,000 shares
@ $0.469, valued at
$25.8k
|
|
| 12/09/2021 |
4
| Praill Anthony Scott (CFO) has filed a Form 4 on Kintara Therapeutics, Inc.|
Txns:
| Bought 28,700 shares
@ $0.677, valued at
$19.4k
|
|
| 12/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/24/2021 |
4
| Johnson Laura L. (Director) has filed a Form 4 on Kintara Therapeutics, Inc.|
Txns:
| Bought 3,000 shares
@ $0.7423, valued at
$2.2k
|
|
| 11/10/2021 |
4
| HOFFMAN ROBERT (President and CEO) has filed a Form 4 on Kintara Therapeutics, Inc.|
Txns:
| Granted 3,519,170 options to buy
@ $0.96, valued at
$3.4M
|
|
| 09/22/2021 |
4
| Murphy Keith (Director) has filed a Form 4 on Kintara Therapeutics, Inc.|
Txns:
| Granted 100,000 options to buy
@ $1.24, valued at
$124k
|
|
| 09/22/2021 |
4
| TOTH ROBERT JOSEPH JR (Director) has filed a Form 4 on Kintara Therapeutics, Inc.|
Txns:
| Granted 100,000 options to buy
@ $1.24, valued at
$124k
|
|
| 09/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/22/2021 |
4
| Johnson Laura L. (Director) has filed a Form 4 on Kintara Therapeutics, Inc.|
Txns:
| Granted 100,000 options to buy
@ $1.24, valued at
$124k
|
|
| 05/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/03/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 04/29/2021 |
4
| Brown Dennis M (Chief Scientific Officer) has filed a Form 4 on Kintara Therapeutics, Inc.|
Txns:
| Acquired 6 shares
@ $0
Converted 750 shares
@ $0
Converted 3,000 convertible preferred
@ $0 |
|
| 04/29/2021 |
4
| Praill Anthony Scott (CFO) has filed a Form 4 on Kintara Therapeutics, Inc.|
Txns:
| Acquired 8 shares
@ $0
Converted 938 shares
@ $0
Converted 3,750 convertible preferred
@ $0 |
|
| 04/29/2021 |
4
| TOTH ROBERT JOSEPH JR (Director) has filed a Form 4 on Kintara Therapeutics, Inc.|
Txns:
| Acquired 3 shares
@ $0
Converted 325 shares
@ $0
Converted 1,300 convertible preferred
@ $0 |
|
| 03/31/2021 |
4
| TOTH ROBERT JOSEPH JR (Director) has filed a Form 4 on Kintara Therapeutics, Inc.|
Txns:
| Acquired 8 shares
@ $0 |
|
| 03/31/2021 |
4
| Brown Dennis M (Chief Scientific Officer) has filed a Form 4 on Kintara Therapeutics, Inc.|
Txns:
| Acquired 17 shares
@ $0 |
|
| 03/31/2021 |
4
| Praill Anthony Scott (CFO) has filed a Form 4 on Kintara Therapeutics, Inc.|
Txns:
| Acquired 22 shares
@ $0 |
|
| 01/04/2021 |
4
| Brown Dennis M (Chief Scientific Officer) has filed a Form 4 on Kintara Therapeutics, Inc.|
Txns:
| Acquired 17 shares
@ $0 |
|
| 01/04/2021 |
4
| TOTH ROBERT JOSEPH JR (Director) has filed a Form 4 on Kintara Therapeutics, Inc.|
Txns:
| Acquired 8 shares
@ $0 |
|
| 01/04/2021 |
4
| Praill Anthony Scott (CFO) has filed a Form 4 on Kintara Therapeutics, Inc.|
Txns:
| Acquired 22 shares
@ $0 |
|
| 09/30/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/30/2020 |
4
| Praill Anthony Scott (CFO) has filed a Form 4 on Kintara Therapeutics, Inc.|
Txns:
| Acquired 22 shares
@ $0 |
|
| 09/30/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/24/2020 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 09/17/2020 |
4
| Praill Anthony Scott (CFO) has filed a Form 4 on Kintara Therapeutics, Inc.|
Txns:
| Granted 606,557 options to buy
@ $1.7, valued at
$1M
|
|
|